Literature DB >> 20849894

A new fluorescent imaging of renal inflammation with RCP.

Kentaro Nakamura1, Yasuhiko Tabata.   

Abstract

The objective of this study is to design a fluorescent imaging agent with R-Gel, one of the recombinant polymers (RCP), for renal inflammation. The R-Gel based on human type I collagen has multiple Arg-Gly-Asp (RGD) motifs which are ligands for some types of integrin receptors on the cell surface. After intravenous administration of R-Gel labeled by Cy7 of a fluorescent dye to three animal models of nephritis mousse, interstitial nephritis (by using UUO model mice), glomerulonephritis (HIGA mice), and ischemia-reperfusion injured kidney (I/R mice), the extent of fluorescent imaging at the renal inflammation was assessed. The Cy7-labeled R-Gel was accumulated in the inflammation site to a significantly greater extent than in the normal one at 24h after administration. The renal pattern of fluorescent imaging was similar to that of administration anti-Mac1 antibody. Taken together, it is conceivable that the R-Gel was targeted to macrophages infiltrated into the inflammation site of kidney.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20849894     DOI: 10.1016/j.jconrel.2010.09.005

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  9 in total

1.  Minimally invasive, longitudinal monitoring of biomaterial-associated inflammation by fluorescence imaging.

Authors:  Shivaram Selvam; Kousik Kundu; Kellie L Templeman; Niren Murthy; Andrés J García
Journal:  Biomaterials       Date:  2011-08-02       Impact factor: 12.479

2.  Paradigms in Fluorescence Molecular Imaging: Maximizing Measurement of Biological Changes in Disease, Therapeutic Efficacy, and Toxicology/Safety.

Authors:  Jeffrey D Peterson
Journal:  Mol Imaging Biol       Date:  2019-08       Impact factor: 3.488

3.  A Novel Bone Substitute Based on Recombinant Type I Collagen for Reconstruction of Alveolar Cleft.

Authors:  Masaaki Ito; Taku Toriumi; Takahiro Hiratsuka; Hideto Imura; Yasunori Akiyama; Ichinnorov Chimedtseren; Yoshinori Arai; Kazuhiro Yamaguchi; Akihiko Azuma; Ken-Ichiro Hata; Nagato Natsume; Masaki Honda
Journal:  Materials (Basel)       Date:  2021-04-29       Impact factor: 3.623

4.  Petaloid recombinant peptide enhances in vitro cartilage formation by synovial mesenchymal stem cells.

Authors:  Mana Naritomi; Mitsuru Mizuno; Hisako Katano; Nobutake Ozeki; Koji Otabe; Keiichiro Komori; Shizuka Fujii; Shizuko Ichinose; Kunikazu Tsuji; Hideyuki Koga; Takeshi Muneta; Ichiro Sekiya
Journal:  J Orthop Res       Date:  2018-06-13       Impact factor: 3.494

5.  Enhancement of Cellular Adhesion and Proliferation in Human Mesenchymal Stromal Cells by the Direct Addition of Recombinant Collagen I Peptide to the Culture Medium.

Authors:  Koji Muraya; Tomoyuki Kawasaki; Takeshi Yamamoto; Hidenori Akutsu
Journal:  Biores Open Access       Date:  2019-11-22

6.  Bone formation potential of collagen type I-based recombinant peptide particles in rat calvaria defects.

Authors:  Yasunori Akiyama; Masaaki Ito; Taku Toriumi; Takahiro Hiratsuka; Yoshinori Arai; Sho Tanaka; Taku Futenma; Yuhki Akiyama; Kazuhiro Yamaguchi; Akihiko Azuma; Ken-Ichiro Hata; Nagato Natsume; Masaki Honda
Journal:  Regen Ther       Date:  2020-12-24       Impact factor: 3.419

7.  Appropriate pore size for bone formation potential of porous collagen type I-based recombinant peptide.

Authors:  Shoji Yamahara; Jorge Luis Montenegro Raudales; Yasunori Akiyama; Masaaki Ito; Ichinnorov Chimedtseren; Yoshinori Arai; Taku Wakita; Takahiro Hiratsuka; Ken Miyazawa; Shigemi Goto; Masaki Honda
Journal:  Regen Ther       Date:  2022-08-29       Impact factor: 3.651

8.  Serial non-invasive monitoring of renal disease following immune-mediated injury using near-infrared optical imaging.

Authors:  Yong Du; Shion An; Li Liu; Li Li; Xin J Zhou; Ralph P Mason; Chandra Mohan
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

9.  An on-site preparable, novel bone-grafting complex consisting of human platelet-rich fibrin and porous particles made of a recombinant collagen-like protein.

Authors:  Tsuneyuki Tsukioka; Takahiro Hiratsuka; Masayuki Nakamura; Taisuke Watanabe; Yutaka Kitamura; Kazushige Isobe; Toshimitsu Okudera; Hajime Okudera; Akihiko Azuma; Kohya Uematsu; Koh Nakata; Tomoyuki Kawase
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2018-10-01       Impact factor: 3.368

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.